% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Sektioglu:130541,
author = {I. M. Sektioglu$^*$ and R. Carretero$^*$ and N. Bender$^*$
and C. Bogdan and N. Garbi and V. Umansky$^*$ and L.
Umansky$^*$ and K. Urban$^*$ and C. Knebel Döberitz$^*$ and
V. Somasundaram and D. Wink and P. Beckhove$^*$ and G.
Hämmerling$^*$},
title = {{M}acrophage-derived nitric oxide initiates {T}-cell
diapedesis and tumor rejection.},
journal = {OncoImmunology},
volume = {5},
number = {10},
issn = {2162-402X},
address = {Austin, Tex.},
publisher = {Landes Bioscience},
reportid = {DKFZ-2017-05620},
pages = {e1204506 -},
year = {2016},
abstract = {In tumor biology, nitric oxide (NO) is generally regarded
as an immunosuppressive molecule that impedes T-cell
functions and activation of endothelial cells. Contrasting
with this view, we here describe a critical role for NO
derived from inducible nitric oxide (iNOS)-expressing tumor
macrophages in T-cell infiltration and tumor rejection as
shown by iNOS gene deletion, inhibition of iNOS, or NO
donors. Specifically, macrophage-derived NO was found to
induce on tumor vessels adhesion molecules that were
required for T-cell extravasation. Experiments with human
endothelial cells revealed a bimodal dose-dependent effect
of NO. High doses of NO donors were indeed suppressive but
lower, more physiological concentrations, induced adhesion
molecules in an NFkB-dependent pathway and preferentially
activated transcription of genes involved in lymphocyte
diapedesis. iNOS(+) macrophages in tumors appear to generate
precisely the amount of NO that promotes endothelial
activation and T-cell infiltration. These results will be
valuable for the development of strategies designed to
overcome the paucity of T-cell infiltration into tumors that
is a major obstacle in clinical cancer immunotherapy.},
cin = {D030 / G181 / G300 / G808 / D015},
ddc = {610},
cid = {I:(DE-He78)D030-20160331 / I:(DE-He78)G181-20160331 /
I:(DE-He78)G300-20160331 / I:(DE-He78)G808-20160331 /
I:(DE-He78)D015-20160331},
pnm = {314 - Tumor immunology (POF3-314)},
pid = {G:(DE-HGF)POF3-314},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:27853636},
pmc = {pmc:PMC5087300},
doi = {10.1080/2162402X.2016.1204506},
url = {https://inrepo02.dkfz.de/record/130541},
}